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ABSTRACT Aspergillus fumigatus infects up to 50% of cystic fibrosis (CF) patients and may play a role
in progressive lung disease. As cystic fibrosis transmembrane conductance regulator is expressed in cells of
the innate immune system, we hypothesised that impaired antifungal immune responses play a role in
CF-related Aspergillus lung disease.
Peripheral blood mononuclear cells, polymorphonuclear cells (PMN) and monocytes were isolated from
blood samples taken from CF patients and healthy volunteers. Live-cell imaging and colorimetric assays
were used to assess antifungal activity in vitro. Production of reactive oxygen species (ROS) was measured
using luminol-induced chemiluminescence and was related to clinical metrics as collected by case report
forms.
CF phagocytes are as effective as those from healthy controls with regards to phagocytosis, killing and
restricting germination of A. fumigatus conidia. ROS production by CF phagocytes was up to four-fold
greater than healthy controls (p<0.05). This effect could not be replicated in healthy phagocytes by
priming with lipopolysaccharide or serum from CF donors. Increased production of ROS against
A. fumigatus by CF PMN was associated with an increased number of clinical exacerbations in the
previous year (p=0.007) and reduced lung function (by forced expiratory volume in 1 s) (p=0.014).
CF phagocytes mount an intrinsic exaggerated release of ROS upon A. fumigatus stimulation which is
associated with clinical disease severity.
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Introduction
Cystic fibrosis (CF) is the most common life shortening inherited disease among Caucasians with an
estimated prevalence of 0.74 per 10000 in Europe [1]. Mutations in the gene encoding the cystic fibrosis
transmembrane conductance regulator (CFTR) in epithelial cells affect mucus fluid dynamics and immune
function, which promotes pathogen survival and lung inflammation [2]. CFTR expression has also been
demonstrated in cells of the innate and adaptive immune system [3, 4] and is critical for normal function [5].
In vitro studies have demonstrated that CF monocytes and neutrophils display reduced killing activity
against Pseudomonas aeruginosa [6]. The underlying molecular mechanisms appear to be phagocyte
specific and include impaired chloride transport, abnormal complement activation and defective
autophagy [6–8]. Reduced killing of Burkholderia cepacia by CF macrophages has also been reported and
linked to defective autophagy [9].
To date, exploration of the innate immune response of CF phagocytes has focussed on typical CF
bacterial pathogens, such as P. aeruginosa and B. cepacia [6–9]. More recently, however, it has been
suggested that the ubiquitous environmental fungus Aspergillus fumigatus may play a critical role in CF
lung disease. A. fumigatus can cause a wide range of disease as a function of the host response.
Pulmonary aspergillosis ranges from angio-invasive disease with a high fungal burden in patients with a
profoundly weakened immune system, to allergic disease with exaggerated inflammatory responses
damaging the host tissue as seen in allergic bronchopulmonary aspergillosis (ABPA) [10]. It has been
reported that up to 58% of CF patients are colonised with A. fumigatus [11] and that an estimated
47.7% of CF adults are affected by either ABPA or Aspergillus infection [12]. In addition, persistent
A. fumigatus infection in CF is adversely correlated with lung function and hospitalisation [13, 14]. The
aim of the current study was to explore the antifungal defence mechanisms of CF phagocytes, to
compare them with those of healthy controls and to relate them to clinical metrics of CF disease
severity.
Material and methods
A single centre cross-sectional study was conducted. Additional details on the methods are provided in the
supplementary material.
Participants
Patients attending the adult CF clinic at Aberdeen Royal Infirmary (Aberdeen, UK) were invited to
participate. The inclusion criteria were: CF-related lung disease, aged ⩾18 years, stable clinical condition
for >4 weeks. Lung-transplant recipients were excluded as well as those on steroids or other
anti-inflammatory therapy. Healthy control participants were drawn from the staff working in the Institute
of Medical Sciences (University of Aberdeen). The study was approved by the North of Scotland Research
Ethics Service (14/NS/1072) and all participants provided written informed consent. Participants were
asked to provide a venous blood sample (minimum 10 mL and maximum 40 mL) using standard
procedures. Clinical data from each participating CF patient was collected and included: CF genotype,
forced expiratory volume in 1 s (FEV1), body mass index (BMI), age, CF-related diabetes, Aspergillus IgG
and IgE, days in hospital, pulmonary exacerbations, Ivacaftor treatment, sputum culture results and
antimicrobials prescribed over the previous year.
Human peripheral blood phagocytes
Peripheral blood mononuclear cell (PBMC) and polymorphonuclear cell (PMN) fractions were isolated
from EDTA blood samples by density gradient centrifugation. Monocytes (MNC) were purified from the
PBMC fraction using CD14+ microbeads (Miltenyi Biotec, UK) according to the manufacturer’s protocol.
Microorganisms
Conidia of the V45-07 (clinical isolate) and dsRed A293-A. fumigatus strains of A. fumigatus were used.
The lab reference strain of P. aeruginosa was PA01 (see supplementary material).
Live-cell video microscopy
The dsRed A293-A. fumigatus was stained with AF633 (Fluorescent Aspergillus Reporter (FLARE) conidia)
as previously described [15]. To an eight well glass-bottomed microslide was added PMN or MNC
(1.2×105), which was then stimulated with FLARE conidia (3.6×105). Imaging was performed with a
spinning disk confocal microscope.
Fungicidal activity
XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay was used to
assess fungal viability [18]. A 96-well filter plate was seeded with PBMC (5×105), MNC (5×105)
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or PMN (1×105). Subsequently, A. fumigatus conidia (1×105) was added and the whole incubated for
18 h. Cells were lysed, incubated for 2 h with XTT–Menadione solution and absorbance was
measured.
Oxidative burst
Oxygen radical production was evaluated by luminol-based chemiluminescence as previously published [16].
PMN, PBMC or MNC (5×105) were incubated with A. fumigatus conidia (5×107 per mL), latex beads
(5×107 per mL), depleted zymosan (200 µg·mL−1), lipopolysaccharide (LPS; 50 ng·mL−1) or P. aeruginosa
(5×107 per mL).
Statistical considerations
Nonparametric tests (Mann−Whitney, Spearman’s rank correlation coefficient (Spearman’s rho),
Jonckheere−Tepestra) were used for all analyses using IBM SPSS Statistics v24.0 (IBM Corp, Armonk, NY,
USA) and GraphPad Prism v5.04 (GraphPad Software, La Jolla, CA, USA). Reactive oxygen species (ROS)
production over time from CF and control cells was analysed using repeated measures ANOVA with
Greenhouse–Geisser correction.
Results
Clinical characteristics of participants
Of the 60 eligible patients attending the clinic, 30 CF patients participated in the study (median age
32 years (range 18–67 years); 69% male). All of the participants with CF were either homozygous or
heterozygous for the Phe508del mutation. Median BMI was 22.3 (range 18.3–29) and median FEV1 was
50% predicted (range 26–92% predicted). Three patients received Ivacaftor, 17 received anti-Pseudomonas
inhalation antibiotics, and one received antifungal therapy. Sputum grew A. fumigatus and P. aeruginosa in
36% and 72% of the patients, respectively. Healthy participants were between 18 and 60 years of age.
Phagocytic and antifungal activity of cystic fibrosis phagocytes
PMN and MNC from CF and control subjects were co-incubated with A. fumigatus conidia and uptake of
conidia was imaged with live-cell video microscopy. No differences were observed between CF and healthy
phagocytes in either the proportion of cells containing conidia (figure 1a) or in the number of conidia
contained within each cell. To determine the ability of phagocytes to kill A. fumigatus, live-cell imaging
using FLARE conidia was performed. FLARE conidia were not killed within a 6-h incubation period with
either neutrophils or monocytes for both healthy and CF donors (data not shown). No differences were
observed in the proportion of germinating conidia when co-incubated with either PMN or MNC at any of
the measured time points (figure 1b). XTT colorimetric assay demonstrated that CF PBMC had a significantly
higher mean fungicidal activity (78.6%±3.8%) compared to healthy PBMC (61.5%±2.3%) (p=0.002). No
significant differences were observed in the fungicidal activity of PMN (45%±12% versus 41.5%±6.4%) or
MNC (65.7%±2.9% versus 64.4%±4.6%) from CF and healthy controls, respectively (figure 1c).
Reactive oxygen species production by cystic fibrosis phagocytes
ROS production after incubation with A. fumigatus conidia was significantly increased by CF PMN,
PBMC and MNC when compared to healthy controls (figures 2a–d). CF PMN, PBMC and MNC showed
a three- to four-fold increase in total ROS production over 2 h of stimulation compared to healthy cells
(p=0.01, p=0.01 and p=0.038, respectively). Analysing the 2-hour ROS curves gives p=0.048 for PMN,
p=0.035 for PBMC and p=0.372 for MNC. Pre-incubation of phagocytes with cytochalasin B (Cyto-B)
abolished ROS production by PMN and PBMC stimulated with A. fumigatus, demonstrating that ROS
production is phagocytosis dependent (figures 3a,b). No reduction in ROS production was observed when
TLR4 or Dectin-1 were blocked on PMN and PBMC before A. fumigatus stimulation. This was similar for
healthy and CF phagocytes (supplementary figure S1). To determine if the increased ROS production by
CF phagocytes was a compensation mechanism necessary for adequate killing of A. fumigatus, the
production of ROS was blocked by diphenyleneiodonium chloride (DPI) which resulted in impaired
fungicidal activity. CF and healthy PBMC treated with DPI displayed reduced killing activity when
compared to controls (70.4%±1.8% versus 80.1%±2.4% (p=0.03) and 57.7%±2.8% versus 75%±2.3%
(p=0.01), respectively) (figure 4a). Both CF and healthy PMN showed a >50% drop in fungicidal activity
due to DPI but did not reach statistical significance for either healthy (18.7%±13.5% versus 47.4%±12.8%
(p=0.13)) or CF (34.9%±20.6% versus 76.7%±5.1% (p=0.31)) cells (figure 4b). No differences were found
in the relative decrease in fungicidal activity between healthy and CF phagocytes.
Increased respiratory burst in cystic fibrosis phagocytes is non-specific
In order to assess if the increased ROS production by CF phagocytes was specific to A. fumigatus,
cells were stimulated with latex beads of similar size to the A. fumigatus conidia, depleted zymosan or LPS.
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A two-fold increase in ROS production by CF PMN was observed across all conditions and similarly for
CF PBMC except for LPS stimulation (figures 5a,b). However, the relative difference in ROS production
between healthy and CF phagocytes remained most pronounced upon stimulation with A. fumigatus
conidia.
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FIGURE 1 Phagocytosis and antifungal activity for phagocytes taken from healthy and CF donors. For
phagocytosis (a) and fungal germination (b), polymorphonuclear cells (PMN) and monocytes (MNC) were
co-incubated with FLuorescent Aspergillus REporter (FLARE) conidia in a 1:3 ratio and imaged directly with
confocal microscopy. The proportion of cells containing conidia was assessed 4 h post-inoculation. Error bars
indicate SEM for three healthy and three CF donors. For fungicidal activity (c), PMN (5×105 per mL), peripheral
blood mononuclear cells (PBMC) and MNC (2.5×106 per mL) were stimulated with Aspergillus fumigatus
conidia (2.5×106 per mL) for 18 h and fungal metabolic activity was assessed with an XTT (2,3-bis
(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay. Error bars indicate SEM for eight
healthy and eight CF donors for PMN and PBMC and for four healthy and four CF donors for MNC. *: p<0.05
(Mann–Whitney U-test).
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To assess if peripheral CF blood phagocytes are at a higher state of activation due to soluble serum factors,
cells were pre-incubated with either pooled healthy or CF serum or LPS before stimulation with
A. fumigatus, beads or zymosan. Pre-incubation with LPS did not affect the ROS production by CF and
healthy PMN upon stimulation with either A. fumigatus, beads or zymosan (figure 6a). In contrast, ROS
production by both CF and healthy PBMC was increased approximately two-fold against depleted
zymosan and three-fold against beads after pre-incubation with LPS (p<0.05) (figure 6b). Under all
conditions tested the ROS production of healthy phagocytes was much less than that produced by CF
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FIGURE 2 Production of reactive oxygen species (ROS) by phagocytes from healthy and CF donors. Polymorphonuclear cells (PMN) (a), peripheral
blood mononuclear cells (PBMC) (b) and monocytes (MNC) (c) (2.5×106 per mL) were stimulated with Aspergillus fumigatus conidia (5×107 per mL)
and chemiluminescence was measured directly (as relative light units (RLUs)·s–1 over a 2-h period). The total ROS production (d) was calculated
as the area under the curve (AUC). Error bars indicate SEM for four-to-six healthy and four-to-eight CF donors. *: p<0.05 (Mann–Whitney U-test).
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FIGURE 3 Effect of inhibition of phagocytosis on the production of reactive oxygen species (ROS) against Aspergillus fumigatus. ROS production by
polymorphonuclear cells (PMN) (a) and peripheral blood mononuclear cells (PBMC) (b) (2.5×106 per mL) is shown after pre-incubation with
cytochalasin-B (Cyto-B) (5 µg·mL–1) and stimulation with Aspergillus fumigatus conidia (5×107 per mL). Error bars indicate SEM for four healthy and
four CF donors. RLU: relative light unit.
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phagocytes. Pre-incubating healthy PMN and PBMC with CF serum did not affect the ROS production
against A. fumigatus conidia and beads compared to pre-incubation with healthy serum (figures 6c and d).
Cystic fibrosis polymorphonuclear cell production of reactive oxygen species against
Pseudomonas is not affected
To better understand the hyperresponsive ROS production by CF PMN the cells were incubated with the
exact same amount of A. fumigatus conidia, P. aeruginosa and beads of different sizes (figure 7). ROS
production against P. aeruginosa was, remarkably, higher in absolute amounts but similar for CF and
healthy PMN. A four-fold increase in ROS production was observed against A. fumigatus when comparing
healthy and CF PMN (p=0.004). Furthermore, CF PMN displayed similar ROS production against 0.5 µm
beads compared to healthy controls; however, upon increasing bead size a strong relative increase in ROS
production was observed by CF compared to healthy PMN, with a 3-fold increase against 6 µm beads
(p=0.0012).
Polymorphonuclear cell reactive oxygen species induced by A. fumigatus and clinical metrics
ROS production did not differ between homozygous and heterozygous dF508 CF donors (data not
shown). Increased ROS production by CF PMN was highly and significantly correlated with the number of
exacerbations in the previous year (rho=0.705, p=0.007) and lung function. CF patients with FEV1 ⩽50%
predicted exhibited higher PMN ROS production than those with a FEV1 >50% (p=0.014) (figure 8). ROS
responses were comparable for patients with and without Aspergillus sensitisation (supplementary figure S2).
No associations were found with positive Aspergillus IgE or IgG levels. Remarkably, ROS responses were
more pronounced in those patients without Aspergillus cultured from their sputum in the previous year
(4.71-fold differences in ROS production (range 2.61–7.31), p=0.03).
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FIGURE 4 Pre-treatment of phagocytes from healthy and CF donors with diphenyleneiodonium chloride (DPI).
The effect of DPI pre-incubation on the fungicidal activity of peripheral blood mononuclear cells (PBMC)
(a) (2.5×106 per mL) and polymorphonuclear cells (PMN) (b) (5×105 per mL) against Aspergillus fumigatus
(2.5×106 per mL) was assessed by XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-
5-carboxanilide) colorimetric assay. Error bars indicate SEM for five healthy and five CF donors. *: p<0.05
(Mann–Whitney U-test).
100 000
75 000
50 000
25 000
a)
0
To
ta
l R
O
S 
pr
od
uc
tio
n
AU
C 
ov
er
 2
 h
A. fumigatus Beads Zymosan LPS A. fumigatus Beads Zymosan LPS
Healthy PBMC
CF PBMC
Healthy PMN
CF PMN
30 000
22 500
15 000
7500
b)
0
To
ta
l R
O
S 
pr
od
uc
tio
n
AU
C 
ov
er
 2
 h
*
FIGURE 5 Specificity of production of reactive oxygen species (ROS) against Aspergillus fumigatus conidia by
phagocytes from healthy and CF donors. Polymorphonuclear cells (PMN) (a) (2.5×106 per mL) and peripheral
blood mononuclear cells (PBMC) (b) (2.5×106 per mL) were stimulated with A. fumigatus conidia (5×107 per
mL), 2 µm latex beads (5×107 per mL), depleted zymosan (200 µg·mL–1) and lipopolysaccharide (LPS)
(50 ng·mL–1). Total ROS production is shown as the area under the curve (AUC) over 2 h (mean±SEM) for five
healthy and three CF donors. *: p<0.05 (Mann–Whitney U-test).
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Discussion
The results from our study show that CF peripheral blood phagocytes are as effective as healthy cells in
phagocytosis, killing and restricting germination of A. fumigatus conidia. However, CF phagocytes
displayed exaggerated ROS production upon stimulation with A. fumigatus conidia compared to healthy
controls. Abolishing ROS production by pre-treating the phagocytes with DPI significantly reduced fungal
killing by both CF and healthy phagocytes similarly, demonstrating that the increased ROS production by
CF phagocytes does not mask impaired fungal killing. ROS production was shown to be
phagocytosis-dependent but not dependent on Dectin-1 and TLR4 signalling. We were able to show that
the absence of a functional CFTR protein results in aberrant ROS production upon stimulation with
A. fumigatus but that this is not observed for P. aeruginosa. Of clinical importance, the increased ROS
production by CF PMN against A. fumigatus was highly correlated with the number of clinical
exacerbations in the previous year and reduced lung function.
To our best knowledge, this is the first human study exploring the host–fungus interaction aimed at a
better understanding of the role of a functional CFTR protein in innate antifungal immunity. Although
associations between A. fumigatus and accelerated lung function decline in CF patients and increased
hospitalisations have been reported, the clinical importance of A. fumigatus infections in CF remains less
than clear and management strategies vary widely. Improving our insights into the pathophysiology of
Aspergillus infections in the CF host will help to establish the clinical importance of this fungus in the
progressive lung disease of CF and will assist in the development of targeted treatment modalities.
In this study peripheral blood phagocytes from CF patients were as effective as healthy controls in killing
A. fumigatus, with even an increased fungicidal activity by CF PBMC compared to healthy cells. This was
most likely due to an enhanced monocyte fraction within the CF PBMC population, as isolated CF MNC
displayed no difference compared to healthy MNC. Fungicidal activity seems to be less influenced by a
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FIGURE 6 Effect of pre-treatment with lipopolysaccharide (LPS) or cystic fibrosis (CF) serum on the production of reactive oxygen species (ROS) by
phagocytes from healthy and CF donors. ROS production by LPS pre-treated healthy and CF polymorphonuclear cells (PMN) (a) (2.5×106 per mL)
and peripheral blood mononuclear cells (PBMC) (b) (2.5×106 per mL) was measured upon stimulation with Aspergillus fumigatus conidia (5×107 per
mL), depleted zymosan (200 µg·mL–1) or 2 µm latex beads (5×107 per mL). Total ROS production, as calculated by the area under the curve (AUC)
of relative light units (RLUs) by chemiluminescence over 1 h, is shown compared to non-primed controls. Error bars indicate ±SEM for five healthy
and three CF donors. Total ROS production by healthy PMN (c) (2.5×106 per mL) and PBMC (d) (2.5×106 per mL) incubated with 20% healthy or CF
serum and stimulated with A. fumigatus conidia (5×107 per mL) or 2 µm latex beads (5×107 per mL) was also determined. Error bars indicate ±SEM
for five healthy donors.
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defective CFTR protein, as others have demonstrated that CF neutrophils display reduced bactericidal
activity against P. aeruginosa [6].
Significantly increased ROS production was shown by CF PMN, PBMC and MNC upon stimulation with
A. fumigatus conidia compared to healthy controls. Data from studies using specific phagocyte
populations, such as CF neutrophils and monocyte-derived macrophages, have shown conflicting results
regarding ROS production in vitro upon stimulation with phorbol myristate acetate (PMA), N-formyl-
methionyl-leucyl-phenylalanine (fMLP) or P. aeruginosa [17–20]. Interaction with fungal organisms has
not been studied before and it seems likely that micro-organism-/stimulus-specific pathways do result in
specific ROS responses. We did not observe a difference in ROS production against P. aeruginosa when
comparing CF and healthy PMN although a four-fold increase in ROS was shown against A. fumigatus.
Dectin-1 and TLR4, which have been described as major pathogen recognition receptors (PRR) for
A. fumigatus, are known to recognise conidia after uptake and binding and are associated with the
initiation of an oxidative response [21–25]. However, blocking Dectin-1 and TLR4 recognition did not
result in decreased ROS production by either CF or healthy phagocytes upon A. fumigatus stimulation. We
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FIGURE 8 Correlation of excessive reactive oxygen species (ROS) production to clinical disease severity. ROS
production against Aspergillus fumigatus by polymorphonuclear cells (PMN) from 13 cystic fibrosis (CF)
patients (compared to PMN from healthy patients) was correlated with the number of exacerbations in the
previous year (a). Analysis was performed using Spearman’s rank correlation coefficient (Spearman’s rho). In
addition, the 13 CF patients were divided into two groups based on percentage predicted forced expiratory
volume in 1 s (FEV1) scores and their ROS production was compared. *: p<0.05 (Mann–Whitney U-test).
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FIGURE 7 Effect on production of reactive oxygen species (ROS) by polymorphonuclear cells (PMN) from
healthy and CF donors on treatment with different sizes of bead and Pseudomonas aeruginosa. PMN (2.5×106
per mL) were stimulated with beads of different sizes (0.5–6 µm; 5×107 per mL), Aspergillus fumigatus conidia
and P. aeruginosa. Chemiluminescence was measured directly for 2 h and total ROS production was
calculated as the area under the curve (AUC). Error bars indicate ±SEM for nine healthy and 11 CF donors.
RLU: relative light unit. *: p<0.05 (Mann–Whitney U-test).
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questioned the specificity of the increased oxidative response observed for A. fumigatus and demonstrated
that CF phagocytes elicited a much stronger oxidative burst compared to healthy phagocytes when
stimulated with beads or with specific ligands for TLR4 and Dectin-1. These results support the
hypothesis reported in the literature that CF immune cells are in a general state of hyperresponsiveness
[26, 27]. Priming of healthy phagocytes with CF serum or LPS did not induce ROS responses comparable
to those seen by CF phagocytes. This suggests either a specific CFTR-related form of intrinsic priming
leading to a higher ROS response or a pathway of activation that takes a longer time to manifest, such as
through epigenetic changes like those recently described in monocytes [28]. Aspergillus sensitisation seems
not to be the explanation for the increased ROS responses as no association was found between the
increased ROS responses and increased Aspergillus specific IgE or IgG levels.
It should be noted that A. fumigatus induced the highest relative increase in ROS production by CF
phagocytes compared to healthy controls. Together with the observation that P. aeruginosa (a potent ROS
inducer) induces similar amounts of ROS from both CF and healthy PMN, this supports the notion of a
micro-organism specific induction of the oxidative response. Aspergillus conidia, at between 2 and 4 µm in
size, are larger than most bacteria and this amplifies dramatically once Aspergillus finds a niche and starts
to germinate. The link between ROS and stimulus size has been demonstrated by PAPAYANNOPOULOS et al. [29],
where pathogen size directly links to the amount of ROS produced, activation of inflammatory pathways
and amount of neutrophils attracted to the site of infection. When combined with our findings, e.g.
positive correlation with ROS production and diameter of the beads, one explanation would be that this
programme of size-dependent ROS production is affected in CF PMN leading to excessive ROS
production against A. fumigatus. ROS is an essential and potent stimulator of NLRP3 and over activation
of the NLRP3 inflammasome in murine CF lungs upon A. fumigatus infection has recently been shown
[30, 31]. Activation of NLRP3 in turn leads to release of interleukin-1β (IL-1β) and using NLRP3 double
knock-out mice or treatment with an IL-1 receptor antagonist has been shown to be protective against
lung damage by Aspergillus [31]. The A. fumigatus induced release of excessive amounts of ROS by human
CF phagocytes may well serve as a trigger for increased activation of the NLRP3 inflammasome followed
by an excessive hyperinflammatory response and subsequent tissue damage in the CF lung.
Increased ROS production against A. fumigatus conidia by CF phagocytes may provide an explanation for
the observed correlation between A. fumigatus colonisation and increased lung damage in CF [14]. The CF
lung is reported to be abundant in neutrophils from early life onwards even in the absence of infectious
stimuli [32, 33]. In addition, it has been shown that bronchoalveolar lavage (BAL) fluids of CF patients
contain higher levels of ROS and that these levels are correlated to the number of neutrophils present [34].
GERSUK et al. [35] showed that healthy monocyte-derived macrophages ingest and phagocytose
A. fumigatus conidia effectively, while at the same time suppressing any significant ROS or
pro-inflammatory cytokine production. The ability to suppress ROS production when it is not required is
likely to be important because ROS are toxic compounds which attract neutrophils and mediate a
multitude of inflammatory pathways [36, 37]. It is estimated that each person inhales at least 100
A. fumigatus conidia a day [38] and as such sustained and persistent ROS production can be expected in the
lungs of CF patients. The significant positive correlation found in our study between A. fumigatus induced
ROS production, the number of clinical exacerbations and impaired lung function support the hypothesis
that Aspergillus colonisation and infection in the CF lung have an adverse impact on disease progression.
In conclusion, CF peripheral blood phagocytes are as effective as those from healthy controls regarding
phagocytosis and killing or controlling the growth of A. fumigatus conidia but show hyperresponsive ROS
production. The excessive amounts of ROS induced by A. fumigatus in CF neutrophils is significantly
correlated to disease severity in terms of clinical exacerbations and lung function. Our data suggest that a
hyperresponsive state in CF phagocytes plays a crucial role in the hyperinflammatory response upon
exposure to A. fumigatus. New interventions to prevent fungal induced ROS production need to be
explored, such as early treatment of Aspergillus infection or targeting the defective molecular pathway
underlying these aberrant responses.
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